CN108676719B - Method for preserving ralstonia solanacearum bacteriophage - Google Patents
Method for preserving ralstonia solanacearum bacteriophage Download PDFInfo
- Publication number
- CN108676719B CN108676719B CN201810465069.XA CN201810465069A CN108676719B CN 108676719 B CN108676719 B CN 108676719B CN 201810465069 A CN201810465069 A CN 201810465069A CN 108676719 B CN108676719 B CN 108676719B
- Authority
- CN
- China
- Prior art keywords
- ralstonia solanacearum
- phage
- ralstonia
- preserving
- solanacearum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/04—Preserving or maintaining viable microorganisms
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention discloses a method for preserving ralstonia solanacearum phage, and the nontoxic ralstonia solanacearum RSsw326-2 disclosed by the invention is preserved in China center for type culture collection with the preservation number of CCTCC NO: M2018197. The invention relates to a nontoxic ralstonia solanacearum which is obtained by separating ralstonia solanacearum from a naturally-diseased tobacco plant and carrying out subculture on the ralstonia solanacearum, the phage stock solution adopted in the proposal is uniformly mixed with an equal amount of ralstonia solanacearum, and glycerol with the final concentration of 40% is added for storage at the temperature of minus 75 ℃ for 12 months, so that the titer is reduced, the storage time of the ralstonia solanacearum phage is long, and higher activity can be kept.
Description
Technical Field
The invention relates to the field of biotechnology and microbial products, in particular to a method for preserving ralstonia solanacearum bacteriophage.
Background
Phage (phase) is a virus that attacks bacteria and is also a genetic material that confers a biological trait to a host bacterium. The phenomenon of bacterial killing by phages was discovered in 1915 by Frederick tewatt (Frederick w.twort), and thus the use of phages to control bacteria has been studied for nearly a hundred years. The phage must be parasitic in live bacteria with strict host specificity, which depends on the molecular structure and complementarity of the phage to adsorb organ and receptor on the surface of the recipient bacterium. Bacteriophages are the most prevalent and widely distributed group of viruses. Usually in some locations full of bacterial flora, such as: phages can be found in soil and in the intestinal tracts of animals. With the development of molecular biology technology, bacteriophage has been widely used in many fields such as disease diagnosis, water treatment, etc. Phage also has become an important tool for molecular and genetic research due to its ability to insert genes into host DNA. Using phage, many elaborate experiments can be designed.
However, in the above processes, the phage strains are required to be preserved, and the existing preservation method of the plant pathogenic bacteria, especially the ralstonia solanacearum phage, has the disadvantages of much reduced titer, short preservation time and undesirable effect, and seriously restricts the development of the application of the phage.
Disclosure of Invention
The invention aims to provide a method for preserving ralstonia solanacearum phage.
In order to achieve the purpose, the invention adopts the following technical scheme:
the method for preserving the ralstonia solanacearum phage comprises the steps of mixing a filtered phage stock solution with the ralstonia solanacearum suspension in a volume ratio of 1:1, adding glycerol with the final concentration of 40%, and preserving at the low temperature of-75 ℃.
The concentration of the ralstonia solanacearum suspension is 108 CFU /mL。
The ralstonia solanacearum strain is ralstonia solanacearumRalstonia solanacearium) RSsw326-2 is preserved in China Center for Type Culture Collection (CCTCC) in 2018, 4 months and 12 days, and the preservation number is M2018197. The address is Wuhan university.
The invention has the advantages that:
the invention mixes the filtered pseudomonas solanacearum phage stock solution with the same amount of pseudomonas solanacearum, adds the glycerol with the final concentration of 40 percent, and stores the mixture at the low temperature of-75 ℃ until the phage still keeps higher activity. The preservation method is reasonable and convenient to operate, does not need a special stabilizer, can be preserved for a long time, and is suitable for phage preservation in a common laboratory.
Drawings
FIG. 1 is a colony map of strain RSsw 326-2.
FIG. 2 plaque assay.
FIG. 3 PCR amplification chart of ralstonia solanacearum specific primers 759F/760R (M: Marker 2000;1: avirulent strain RSsw326-2;2: wild ralstonia solanacearum).
Detailed Description
Example 1
1. Acquisition of ralstonia solanacearum: separating tobacco plants with natural diseases by a dilution coating separation method, selecting a single colony, and purifying for 3-5 times to obtain wild ralstonia solanacearum.
2. Screening of avirulent strains: the method comprises the steps of continuously culturing wild ralstonia solanacearum separated from a naturally-occurring tobacco plant for more than 20 generations, selecting a colony with poor liquidity, carrying out pathogenicity determination, and obtaining a determination result that the strain loses pathogenicity to tobacco, namely a variant strain of ralstonia solanacearum, which is named as RSsw 326-2.
3. Pathogenicity determination:single colonies of the mutant strain obtained by subculture were selected and cultured in NB broth (28 ℃ C., 180 rpm) with shaking to a concentration of about 108CFU/mL, adopting root irrigation to inoculate 5 tobacco seedlings with true leaves, and 30 days after inoculation treatment, the inoculated tobacco does not show symptoms as the same as the tobacco inoculated by clear water contrast, which indicates that the obtained variant strain loses the pathogenicity to the tobacco, namely the avirulent strain Laurella (L) (A.solani)Ralstonia solanacearium)RSsw326-2。
4. Performing PCR amplification on ralstonia solanacearum specific primers: extracting genome DNA of the avirulent strain, and performing PCR amplification by using a ralstonia solanacearum specific primer 759F/760R (GTCGCCGTCAACTCACTTTCC/GTCGCCGTCAGCAATGCGGAATCG) under the following amplification conditions: pre-denaturation at 95 deg.C for 5 min; denaturation at 95 ℃ for 30 s; annealing at 59 ℃ for 30 s; extending at 72 ℃ for 1 min; after extension at 72 ℃ for 10 min. As a result, a specific band of 280bp in size was obtained. See fig. 3.
5. The non-virulent strain RSsw326-2 utilizes 3 disaccharides and 3 hexanols: in basal medium (NH)4H2PO41g、KCl 0.2 g、MgSO4·7H20.2 g of O, 1.0 g of peptone, 80 mg of phenol red, 3 g of agar, adjusting the pH value to 7.4, adding deionized water, fixing the volume to 1L), respectively adding lactose, maltose, cellobiose, mannitol, sorbitol and sweet alcohol which are subjected to filtration sterilization to enable the final concentration to be 1%, subpackaging test tubes, and inoculating a nontoxic strain suspension (the concentration is about 10%) according to the proportion of 1% in each tube, wherein the lactose, maltose, cellobiose, mannitol, sorbitol and sweet alcohol are respectively added to enable the final concentration to be 1%, and the tubes are subpackaged by 3mL8CFU/mL) was placed in a 28 ℃ incubator. The results show that the strain can utilize lactose, maltose, cellobiose, mannitol, sorbitol and sweet alcohol. See table 1.
TABLE 1 utilization of trisaccharide triol by avirulent Strain RSsw326-2
RSsw326-2 has round colony on TTC medium (see figure 1), dark red center, milky white edge and poor fluidity, and 3 disaccharides and 3 hexanols are utilized by strain and ralstonia solanacearum specific primer PCR amplification nodeIdentification of the fruit as Laurella solanacearum: (Ralstonia solanacearium)。
Example 2 avirulent strain host range assay:
the avirulent strain host range was determined using the drop method. The specific operation is as follows:
taking 1mL Log stage Laurella solanacearum (L.), (Ralstonia solanacearium) Adding the culture into a CPG semi-solid culture medium, uniformly mixing, pouring onto a prepared CPG solid agar plate, after solidification, dropwise adding 0.5 mu L of phage stock solution onto the surface of the plate, blow-drying, performing inverted culture at 28 ℃ overnight, and observing the formation condition of the phage plaques at 2 d. The results showed that this strain can be parasitized by the bacterial phage Ralstonia (FIG. 2).
Example 3
(1) Inoculating the strain RSsw326-2 on a CPG plate, inverting, and culturing at 28 ℃ for 24-48h to grow a single colony.
(2) Single colonies of the strain RSsw326-2 were picked up in Erlenmeyer flasks containing 100mL NB medium, and cultured at 28 ℃ with shaking at 180rpm to a concentration of about 108cfu/ml。
(3) Adding 1mL of phage stock solution, mixing, standing for 15min, culturing at 28 deg.C and 130rpm overnight with shaking to completely lyse bacteria.
(4) Centrifuging the co-culture solution at 12000rpm for 5min, and filtering the supernatant with 0.45 μm filter membrane to obtain phage stock solution.
(5) Taking the cultured phage stock solution, measuring the titer of the phage stock solution and recording the phage stock solution for later use.
(6) Titer-determined phage stock (2.29 x 10)10PFU/mL) was treated as follows: firstly, preserving stock solution at room temperature; ② preserving the stock solution at 4 ℃; ③ preserving the stock solution at-20 ℃; fourthly, preserving the stock solution at-75 ℃; fifthly, uniformly mixing the phage stock solution with the same amount of ralstonia solanacearum, adding glycerol with the final concentration of 40% and preserving at-75 ℃;
(7) the titer was determined at 3 months, 6 months, 9 months and 12 months after storage, respectively.
The experimental results are shown in table 2, the survival time and survival condition of the phage are different by different preservation methods, the phage stock solution is preserved for 3 months at normal temperature, and the phage cannot be detected; macrophageThe thallus stock solution is stored for 12 months at 4 ℃, and the titer is reduced by 5 orders of magnitude; the phage stock solution is stored for 12 months at-20 ℃ and 75 ℃, and the titer is reduced by 1 order of magnitude; and phage stock solution with equal amount of 108CFU/mL strain RSsw326-2 is mixed evenly, and glycerol with the final concentration of 40% is added to be stored at the temperature of minus 75 ℃ for 12 months, the titer is in the same order of magnitude, namely the reduction is less, so that the storage method has long storage time on the bacteriophage and can keep higher activity.
TABLE 2 potency assay for Ralstonia solanacearum phages with different storage modes
The above description is only a preferred embodiment of the present invention, and all equivalent changes and modifications made in accordance with the claims of the present invention should be covered by the present invention.
SEQUENCE LISTING
<110> Fujian agriculture and forestry university
<120> method for preserving ralstonia solanacearum phage
<130> 2
<160> 2
<170> PatentIn version 3.3
<210> 1
<211> 21
<212> DNA
<213> Artificial sequence
<400> 1
gtcgccgtca actcactttc c 21
<210> 2
<211> 24
<212> DNA
<213> Artificial sequence
<400> 2
gtcgccgtca gcaatgcgga atcg 24
Claims (1)
1. A method for preserving ralstonia solanacearum phage is characterized in that: the filtered phage stock solution and the ralstonia solanacearum suspension are mixed in a volume ratio of 1:1Mixing, adding 40% glycerol, and storing at-75 deg.C; the concentration of the ralstonia solanacearum suspension is 108CFU/mL; the ralstonia solanacearum is Laurella solanacearum (L.)Ralstonia solanacearium) RSsw326-2 is preserved in China Center for Type Culture Collection (CCTCC) in 2018, 4 months and 12 days, and the preservation number is M2018197.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810465069.XA CN108676719B (en) | 2018-05-16 | 2018-05-16 | Method for preserving ralstonia solanacearum bacteriophage |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810465069.XA CN108676719B (en) | 2018-05-16 | 2018-05-16 | Method for preserving ralstonia solanacearum bacteriophage |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108676719A CN108676719A (en) | 2018-10-19 |
CN108676719B true CN108676719B (en) | 2021-10-22 |
Family
ID=63806506
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810465069.XA Active CN108676719B (en) | 2018-05-16 | 2018-05-16 | Method for preserving ralstonia solanacearum bacteriophage |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108676719B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113150994A (en) * | 2021-04-15 | 2021-07-23 | 上海理工大学 | Low-temperature preservation method for virulent phage |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0172914B1 (en) * | 1984-02-10 | 1990-05-16 | Japan Tobacco Inc. | Pseudomonas solanacearum m4s strain, composition containing the same for controlling soil-borne diseases of solanaceous plant, and method for controlling said soil-borne diseases with the same |
CN104560891A (en) * | 2015-01-08 | 2015-04-29 | 贵州省烟草科学研究院 | Screening method of pseudomonas solanacearum bacteriophage resource |
-
2018
- 2018-05-16 CN CN201810465069.XA patent/CN108676719B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0172914B1 (en) * | 1984-02-10 | 1990-05-16 | Japan Tobacco Inc. | Pseudomonas solanacearum m4s strain, composition containing the same for controlling soil-borne diseases of solanaceous plant, and method for controlling said soil-borne diseases with the same |
CN104560891A (en) * | 2015-01-08 | 2015-04-29 | 贵州省烟草科学研究院 | Screening method of pseudomonas solanacearum bacteriophage resource |
Non-Patent Citations (3)
Title |
---|
一株裂解性青枯雷尔氏菌噬菌体的分离及生物学特性分析;高苗等;《中国农业科学》;20151231;第48卷(第7期);第1.2.3节 * |
无致病力青枯病病菌对番茄青枯病的控病研究;王羽;《中国优秀硕士学位论文全文数据库》;20051231;摘要 * |
青枯雷尔氏菌噬菌体研究进展;苏靖芳等;《土壤与作物》;20170131;第6卷(第1期);全文 * |
Also Published As
Publication number | Publication date |
---|---|
CN108676719A (en) | 2018-10-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2023055862A (en) | Method and composition for treatment and control of plant disease | |
WO2012147928A1 (en) | Agent for preventing bacterial wilt disease, and method for preventing bacterial wilt disease | |
CN108676778B (en) | Bacteriophage for preventing and treating soil-borne bacterial wilt and application thereof | |
US11976265B2 (en) | Method for treatment and control of plant disease | |
CN108699533B (en) | Vibrio parahaemolyticus bacteriophage Vib-PAP-1 and use thereof for inhibiting proliferation of Vibrio parahaemolyticus | |
CN108699532B (en) | Vibrio parahaemolyticus bacteriophage Vib-PAP-2 and use thereof for inhibiting proliferation of Vibrio parahaemolyticus | |
CN108410826B (en) | Method for expanding propagation of ralstonia solanacearum bacteriophage | |
CN108676719B (en) | Method for preserving ralstonia solanacearum bacteriophage | |
CN114196585A (en) | Burkholderia for preventing and treating tomato bacterial wilt and application thereof | |
CN112359001B (en) | Bacillus amyloliquefaciens microbial agent and application thereof | |
CN115960762B (en) | Pseudomonas extreme and application thereof | |
CN114921420B (en) | Richter duck plague bacillus phage | |
CN115418326A (en) | Complex microbial inoculant and application thereof | |
CN114933980A (en) | Streptomyces lividans HJB-XTBG45 for preventing and treating polygonatum sibiricum root rot and application thereof | |
CN113462599A (en) | Biological preparation containing plant source components and microorganism source components and application of biological preparation in prevention and treatment of plant nematode diseases | |
CN115851615B (en) | Separated bacterial wilt phage for mulberries and application thereof | |
CN116790516B (en) | Phage for lysing algicidal bacteria and application thereof | |
CN116769667B (en) | Bacillus tequilensis K3-11 and application thereof | |
CN117546873B (en) | Application of extremely oriental pseudomonas in preventing and treating pepper light mottle virus | |
CN113215111B (en) | Bacteriophage and medical application thereof in preventing and treating endocarditis of broiler chickens | |
CN112760263B (en) | Application of burkholderia in biological prevention and control of aspergillus flavus and peanut storage | |
CN109810997B (en) | Construction method of fusarium graminearum single-stranded circular DNA virus FgGMTV1/HB58 infectious clone | |
CN114854770A (en) | Application of BcSpd1 gene in preventing and treating plant gray mold and improving disease resistance | |
CN114790433A (en) | Streptomyces populi ZJPH2021032 and application thereof in preparation of antibacterial agent | |
CN116948885A (en) | Paenibacillus polymyxa, composition containing same and application of paenibacillus polymyxa |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |